PTGX - Company ID 0001377121
The table below shows Protagonist Therapeutics, Inc's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $128.39M | $97.25M | $186.73M | $125.74M | $123.67M | $117.36M |
| Short-term investments | $438.97M | $321.66M | $154.89M | $111.61M | $203.24M | $188.45M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $577.57M |
| $591.64M |
| $355.58M |
| $243.08M |
| $340.74M |
| $315.61M |
| Property, plant & equipment | $3.86M | $3.19M | $1.20M | $1.56M | $1.80M | $1.46M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $668.19M | $744.73M | $357.95M | $247.93M | $347.69M | $324.47M |
| Accounts payable | $5.34M | $1.61M | $772.00K | $3.64M | $1.60M | $3.08M |
| Total current liabilities | $45.44M | $47.40M | $21.27M | $31.18M | $44.02M | $40.24M |
| Long-term debt | - | - | - | - | - | $9.79M |
| Total liabilities | $53.48M | $69.43M | $21.27M | $32.32M | $47.67M | $44.86M |
| Retained earnings | -$470.67M | -$340.52M | -$615.71M | -$536.75M | -$409.36M | -$283.81M |
| Total equity | $614.71M | $675.29M | $336.68M | $215.61M | $300.02M | $279.61M |